All terms in HP

Label Id Description
Hypoplasia of the iris dilator muscle HP_0008345 [Underdevelopment of the dilatator pupillae.]
Postprandial hyperlactemia HP_0011997 [Abnormally increased level of blood lactate following a meal.]
Increased circulating lactate concentration HP_0002151 [Abnormally increased level of blood lactate (2-hydroxypropanoic acid). Lactate is produced from pyruvate by lactate dehydrogenase during normal metabolism. The terms lactate and lactic acid are often used interchangeably but lactate (the component measured in blood) is strictly a weak base whereas lactic acid is the corresponding acid. Lactic acidosis is often used clinically to describe elevated lactate but should be reserved for cases where there is a corresponding acidosis (pH below 7.35).]
Elevated circulating branched chain amino acid concentration HP_0008344 [Concentration of a branched chain amino acid in the blood above the upper limit of normal.]
Postprandial hyperglycemia HP_0011998 [An increased concentration of glucose in the blood following a meal.]
Abnormal leukocyte physiology HP_0033796 [A functional abnormality of a white blood cell.]
Atrial septal dilatation HP_0011995 [A bulging of the interatrial septum towards one side. In adults, atrial septal aneurysm can be defined as a protrusion of the aneurysm of >10 mm beyond the plane of the atrial septum as measured by transesophageal echocardiography.]
Elevated coagulation factor V activity HP_0011996 [Increased activity of coagulation factor V, Factor V, which is activated to factor Va by means of minute amounts of thrombin (and inactivated by larger amounts of thrombin). Activated factor V (fVa) is a cofactor in the formation of the prothrombinase complex.]
Impaired neutrophil bactericidal activity HP_0011993 [A reduction in the ability of neutrophils to kill bacteria.]
Fibrous crescent HP_0033319 [A type of glomerular crescent characterized by extracapillary fibrosis composed of greater than 75% matrix and of less than 25% cells with or without fibrin, usually associated with disruption of Bowman's capsule and involving over 10% of the capsular circumference.]
Glomerular crescent formation HP_0033316 [Glomerular crescent refers hyperplastic lesions involving 10% or more of the circumference of Bowman's capsule. Crescents can be composed of a variable mixture of epithelial/leukocyte hypercellularity, fibrous matrix, and fibrin.]
Fibrocellular crescent HP_0033318 [A type of glomerular crescent characterized by extracapillary hypercellularity of more than 2 cell layers and involving over 10% of the capsular circumference, composed of 25% to 75% cells with or without fibrin, and the remainder fibrous matrix.]
Cellular crescent HP_0033317 [A type of glomerular crescent characterized by extracapillary hypercellularity of greater than two cell layers and involving more than 10% of the capsular circumference, composed of greater than 75% cells with or without fibrin, and less than 25% fibrous matrix.]
Abnormal Bowman space morphology HP_0033312 [Structural anomaly located in Bowman's space, which represents the beginning of the urinary space and is contiguous with the proximal convoluted tubule of the nephron.]
Visceral epithelial hyaline droplets HP_0033315 [Round to ovoid, Periodic acid-Schiff (PAS)-positive, fuchsinophilic cytoplasmic inclusions within visceral epithelial cells.]
Hyperprolinemia HP_0008358 [An increased concentration of proline in the blood.]
obsolete Combined hyperlipidemia HP_0008356
Factor X activation deficiency HP_0008354 [Reduced ability to transform factor X into its activated form factor Xa.]
Neutral hyperaminoaciduria HP_0008353 [The presence of an abnormally increased concentration of neutral amino acids in the urine. The neutral amino acids are tryptophan, alanine, asparagine, glutamine, histidine, isoleucine, leucine, phenylalanine, serine, threonine, tyrosine and valine.]
Impaired platelet adhesion HP_0008352 [An abnormality of adhesion of thrombocytes. Normally, platelets adhere to collagen in the vascular subendothelium within seconds of injury via a receptor made up of glycoprotein Ia and IIa and GPVI and to vWF via receptor GPIb/IX/V. The adherent platelets then release granules that lead to platelet activation and aggregation.]